DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer-Reference-Cited by-同舟云学术

DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer

Published:2021-03 Issue: Volume:235 Page:105033
ISSN:0009-3084
Container-title:Chemistry and Physics of Lipids
language:en
Short-container-title:Chemistry and Physics of Lipids

Author:

Pindiprolu Sai Kiran S.S.^ORCID,Krishnamurthy Praveen T.^ORCID,Dev Chetan,Chintamaneni Pavan Kumar^ORCID

Funder

DST

FIST

Ministry of Science & Technology, New Delhi

Publisher

Elsevier BV

Subject

Cell Biology,Organic Chemistry,Molecular Biology,Biochemistry

Reference35 articles.

1. Triple negative breast cancer: an Indian perspective;Akhtar;Breast Cancer Targets Ther.,2015

2. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer;Anders;Clin. Breast Cancer,2009

3. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency;Atkinson;Breast Cancer Res.,2013

4. Cancer active targeting by nanoparticles: a comprehensive review of literature;Bazak;J. Cancer Res. Clin. Oncol.,2015

5. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model;Buchsbaum;Clin. Cancer Res.,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies;Biology;2024-07-15

2. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy;Cell Communication and Signaling;2024-05-02

3. Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles;Life;2024-04-10

4. Targeting triple negative breast cancer stem cells using nanocarriers;Discover Nano;2024-03-07

5. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells;Journal of Drug Targeting;2024-02